Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Schubbert S.,,Hyperactive Ras in developmental disorders and cancer,2007,Nature Reviews Cancer,1105,10.1038/nrc2109,United States,Review,San Francisco,0,Journal,2-s2.0-33947594129
Roberts A.,,Germline gain-of-function mutations in SOS1 cause Noonan syndrome,2007,Nature Genetics,407,10.1038/ng1926,United States;United States,Article,Boston;Boston,0,Journal,2-s2.0-33845900943
Tartaglia M.,,Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome,2007,Nature Genetics,404,10.1038/ng1939,Italy,Article,Rome,0,Journal,2-s2.0-33845884026
Gelb B.,,Noonan syndrome and related disorders: Dysregulated RAS-mitogen activated protein kinase signal transduction,2006,Human Molecular Genetics,142,10.1093/hmg/ddl197,United States,Article,New York,1,Journal,2-s2.0-33749003166
Kratz C.,,Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders,2006,Cell Cycle,37,10.4161/cc.5.15.3128,Germany,Review,Freiburg im Breisgau,1,Journal,2-s2.0-33747849281
Zebisch A.,,Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia,2006,Cancer Research,75,10.1158/0008-5472.CAN-05-0115,Austria,Article,Graz,1,Journal,2-s2.0-33645741209
Rodriguez-Viciana P.,,Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome,2006,Science,412,10.1126/science.1124642,United States,Article,San Francisco,0,Journal,2-s2.0-33644696097
Bentires-Alj M.,,Stops along the RAS pathway in human genetic disease,2006,Nature Medicine,166,10.1038/nm0306-283,United States;Belgium,Short Survey,Boston;Liege,0,Journal,2-s2.0-33644829154
Niihori T.,,Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome,2006,Nature Genetics,403,10.1038/ng1749,Japan,Article,Sendai,0,Journal,2-s2.0-33644629727
Schubbert S.,,Germline KRAS mutations cause Noonan syndrome,2006,Nature Genetics,520,10.1038/ng1748,United States,Article,San Francisco,0,Journal,2-s2.0-33644622238
Carta C.,,Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype,2006,American Journal of Human Genetics,170,10.1086/504394,Italy,Article,Rome,1,Journal,2-s2.0-33745265268
Emuss V.,,Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF,2005,Cancer Research,130,10.1158/0008-5472.CAN-05-1683,United Kingdom,Article,London,1,Journal,2-s2.0-27544453376
Aoki Y.,,Germline mutations in HRAS proto-oncogene cause Costello syndrome,2005,Nature Genetics,465,10.1038/ng1641,Japan,Article,Sendai,0,Journal,2-s2.0-27144531386
Komoike Y.,,Zebrafish Polycomb group gene ph2Î± is required for epiboly and tailbud formation acting downstream of FGF signaling,2005,Biochemical and Biophysical Research Communications,10,10.1016/j.bbrc.2005.01.031,Japan,Article,Tokyo,0,Journal,2-s2.0-13744263863
Garnett M.,,Guilty as charged: B-RAF is a human oncogene,2004,Cancer Cell,610,10.1016/j.ccr.2004.09.022,United Kingdom,Review,London,1,Journal,2-s2.0-5444227865
Harris I.S.,,Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload,2004,Circulation,125,10.1161/01.CIR.0000138190.50127.6A,United States,Article,St. Louis,1,Journal,2-s2.0-4043076222
Fragale A.,,Noonan Syndrome-Associated SHP2/PTPN11 Mutants Cause EGF-Dependent Prolonged GAB1 Binding and Sustained ERK2/MAPK1 Activation,2004,Human Mutation,144,10.1002/humu.20005,United States;Italy,Article,New York;Rome,0,Journal,2-s2.0-1542619343
Dumaz N.,,Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras,2003,Journal of Biological Chemistry,192,10.1074/jbc.C300182200,,Article,,1,Journal,2-s2.0-0041529686
Chan E.,,"Mutations in conserved regions 1, 2, and 3 of Raf-1 that activate transforming activity",2002,Molecular Carcinogenesis,10,10.1002/mc.10031,Canada;Canada,Article,Edmonton;Vancouver,0,Journal,2-s2.0-0036219615
Tartaglia M.,,"PTPN11 mutations in noonan syndrome: Molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity",2002,American Journal of Human Genetics,519,10.1086/340847,United States;Italy,Article,New York;Rome,1,Journal,2-s2.0-18344370436
Tartaglia M.,,"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome",2001,Nature Genetics,1156,10.1038/ng772,United States;Italy,Article,New York;Rome,0,Journal,2-s2.0-18344385476
Bueno O.F.,,The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice,2000,EMBO Journal,585,10.1093/emboj/19.23.6341,United States,Article,Cincinnati,0,Journal,2-s2.0-0034383952
Yamazaki T.,,Protein kinase A and protein kinase C synergistically activate the Raf-1 kinase/mitogen-activated protein kinase cascade in neonatal rat,1997,Journal of Molecular and Cellular Cardiology,42,10.1006/jmcc.1997.0488,,Article,,0,Journal,2-s2.0-0031239115
Kimmel C.,,Stages of embryonic development of the zebrafish,1995,Developmental Dynamics,7325,10.1002/aja.1002030302,United States,Article,Eugene,1,Journal,2-s2.0-0029045033
Marshall C.J.,,"MAP kinase kinase kinase, MAP kinase kinase and MAP kinase",1994,Current Opinion in Genetics and Development,873,10.1016/0959-437X(94)90095-7,United Kingdom,Article,London,0,Journal,2-s2.0-0028152333
Heidecker G.,,Mutational activation of c-raf-1 and definition of the minimal transforming sequence,1990,Molecular and Cellular Biology,204,10.1128/MCB.10.6.2503,United States,Article,Frederick,1,Journal,2-s2.0-0025277489
Allanson J.E.,,Noonan syndrome,1987,Journal of Medical Genetics,283,10.1136/jmg.24.1.9,United States,Review,Scottsdale,1,Journal,2-s2.0-0023133725
Noonan J.,,Hypertelorism with Turner Phenotype: A New Syndrome with Associated Congenital Heart Disease,1968,American Journal of Diseases of Children,384,10.1001/archpedi.1968.02100020377005,United States,Article,Lexington,0,Journal,2-s2.0-0014337521
